about
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.Comparison of data from the Cause of Death Registry and the Norwegian Patient Register.Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001-2009: Analyzing time trends and educational inequalities using data from the CVDNOR project.Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project.Validation of data in the Medical Birth Registry of Norway on delivery after a previous cesarean section.Cancer incidence and mortality after treatment with folic acid and vitamin B12.Educational inequalities in acute myocardial infarction incidence in Norway: a nationwide cohort study.Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patientsUse of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score MatchingPrognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project.Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project.Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials.Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project.Time Trends and Educational Inequalities in Out-of-Hospital Coronary Deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) ProjectEffect of the Lookback Period's Length Used to Identify Incident Acute Myocardial Infarction on the Observed Trends on Incidence Rates and Survival: Cardiovascular Disease in Norway Project.Educational inequalities in mortality of patients with atrial fibrillation in Norway.Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease.Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register.Educational inequalities in 28 day and 1-year mortality after hospitalisation for incident acute myocardial infarction--a nationwide cohort study.Prevention: B vitamins and CVD--failure to find a simple solution.Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins.Favourable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project.Health data - simpler and safer access.Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited.Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project).Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway.Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris.Completeness and correctness of acute myocardial infarction diagnoses in a medical quality register and an administrative health registerLow Plasma Vitamin B-6 Status Affects Metabolism through the Kynurenine Pathway in Cardiovascular Patients with Systemic InflammationInjury death certificates without specification of the circumstances leading to the fatal injury - the Norwegian Cause of Death Registry 2005-2014
P50
Q30586300-DBF49A76-59BB-4DB5-9A9E-D36203CB7BCBQ31024844-1BE60DFC-51D2-4F69-BEA7-68488EE28ACBQ31068038-3420B303-8E37-454B-A5D8-98296C1890EFQ31115853-01A01793-C126-4FC3-9197-4777862B3687Q31161884-13C9761C-A31D-4F47-9181-55EF821CE47DQ34020200-494FB873-0B63-4295-9410-73F6DAD9BC4CQ34134175-E198B541-0B07-498E-A6ED-1A0CA7FC4694Q34595749-A1A83F14-6150-49A7-BC1F-4A3F64F46663Q34924389-C04D99F5-0B2A-4AB2-A2E7-54539BDFCFCDQ35647794-D5DE5689-CBB4-41D9-9549-523428711270Q36309695-18A103E7-36CF-462B-9CEA-B732794750B7Q36877727-0EDAD402-07A7-4F1E-884D-19E0BE76BDEFQ37137009-2E2341EA-82A2-477A-8032-54467D73B7C5Q38748834-255130C0-F2B4-44AE-B6A4-69AB19DE1635Q38823420-6254EA31-4C96-4361-8EC3-C8E734D487B0Q38951214-84E50059-599D-44C0-915A-1411B917DFDAQ38997556-AD44D5BA-8FF4-4987-A6E0-F2B990F90703Q39130676-D5D1D4BE-C9C0-4EF6-A1B4-CE639FBDAB09Q39871836-AD293AD9-8DA1-410B-A619-DC2DEE37194DQ40218769-869F4039-C5E8-4816-B408-39AC535A24B5Q41751116-9B2EB350-EEF1-47C1-BAFF-4FB3D71E0130Q42847939-02A9050D-D924-422E-87DC-DCD1E2652ACEQ42941480-F8B56946-3B88-4266-8847-F6C0C2BC496AQ43056383-16A405C6-6703-4E25-8DB2-27CD2BA739D0Q43124579-B198B3A4-76A6-4B4C-9620-AF04693515E0Q43874285-859C64BF-FAC6-4882-9AFF-7A7EB052F7E7Q47963175-93F46AAB-A522-412F-8635-A9177DF59EC6Q50849590-09036B85-DAF8-40D2-8099-75A81BEE2B13Q51244760-BF90D79A-DD35-46AE-8F17-CA3C7B3277F0Q51322784-BE33930F-7F2E-4477-956E-72FEBD82BA54Q51339744-1D1033E2-D0C6-4AED-B879-E1F4BC5EEB47Q57065699-624BD82A-3DF9-49AB-83C4-C10575812EFCQ59275991-A6BF7D4A-DE77-4A96-833F-AED70D1980FBQ60935303-08936204-DFD6-4DE1-A51D-445075974DCA
P50
description
Noors onderzoekster
@nl
Norwegian researcher
@en
norsk forsker
@nb
taighdeoir Ioruach
@ga
name
Marta Ebbing
@ast
Marta Ebbing
@da
Marta Ebbing
@de
Marta Ebbing
@en
Marta Ebbing
@es
Marta Ebbing
@fr
Marta Ebbing
@ga
Marta Ebbing
@nb
Marta Ebbing
@nl
Marta Ebbing
@nn
type
label
Marta Ebbing
@ast
Marta Ebbing
@da
Marta Ebbing
@de
Marta Ebbing
@en
Marta Ebbing
@es
Marta Ebbing
@fr
Marta Ebbing
@ga
Marta Ebbing
@nb
Marta Ebbing
@nl
Marta Ebbing
@nn
prefLabel
Marta Ebbing
@ast
Marta Ebbing
@da
Marta Ebbing
@de
Marta Ebbing
@en
Marta Ebbing
@es
Marta Ebbing
@fr
Marta Ebbing
@ga
Marta Ebbing
@nb
Marta Ebbing
@nl
Marta Ebbing
@nn
P1015
P214
P1015
P106
P21
P214
P27
P31
P569
1963-01-01T00:00:00Z
P734
P735
P7859
viaf-226244736